This product may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information.
1Liu T. et al., The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. Reprint from medRxiv, 10 March 2020.
2Gao Y. et al., Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 Mar 17.
3Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Journal of Autoimmunity. 2020 Jul;111:102452. DOI: 10.1016/j.jaut.2020.102452.
4Mehta, P et al. “COVID-19: consider cytokine storm syndromes and immunosuppression.” March 16, 2020. DOI:https://doi.org/10.1016/S0140-6736(20)30628-0
5Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T, Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19, Journal of Allergy and Clinical Immunology (2020), doi: https://doi.org/10.1016/j.jaci.2020.05.008.
6Instructions for Use for Access IL-6 under EUA (Part Number A83733J.) Data on file Beckman Coulter, Inc.